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http://dxObjectives: Postoperative neurocognitive deficits (POCDs) have been found to occur frequently after cardiac
surgery. Although POCDs have received significant attention in the medical literature and public media, the
true clinical impact of these deficits on patient outcomes and quality of life (QOL) is not well defined.
Methods:Neuropsychometric testing was performed on 696 patients undergoing coronary artery bypass surgery
using a battery of tests divided into 4 domains; memory, attention, speed, and psychomotor function. These were
performed preoperatively, at hospital discharge, and at 3 months postoperatively. POCDs were defined as a drop
in scores by 1 standard deviation in 1 domain or more. QOL was assessed using Short Form 36 and clinical
outcomes were recorded.
Results: POCDs were identified in 265 (38%) patients at discharge and in 132 (19%) at 3 months. There was no
observed difference in mortality or major morbidity in patients with or without POCDs. Predictors of POCDs at
discharge were elevated preoperative creatinine (P ¼ .04), increased cardiopulmonary bypass time (P ¼ .005),
and diabetes (P ¼ .003). At 3 months, patients had improvements in both physical and mental components of
QOL, independent of the occurrence of POCDs (P>.5). Independent predictors of improved QOL included
younger age, severe preoperative anginal symptoms, normal left ventricular function, absence of postoperative
wound infection, but not POCDs.
Conclusions: Neurocognitive deficits can be frequently detected on comprehensive neuropsychometric testing
after cardiac surgery. However, they are not associated with any clinically important differences in patient
outcome or in QOL after surgery. (J Thorac Cardiovasc Surg 2013;145:1545-9)A
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Postoperative neurocognitive deficits (POCDs) have been
reported to occur in 30% to 80% of patients after cardiac
surgery.1 POCDs are subtle changes in higher cognitive
function that can be identified using comprehensive neuro-
psychiatric testing assessing a variety of neurocognitive
domains like memory, attention, speed, and psychomotor
function. Recent studies have identified POCDs in other
populations including patients undergoing major noncar-
diac surgical procedures as well as those undergoing
coronary angiography.2,3 POCDs have received significant
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The Journal of Thoracic and Carbecause of the suggestion that they may contribute to
a delay in postoperative recovery, delayed return to work,
and impaired quality of life (QOL).4 Although the incidence
of POCDs in patients undergoing coronary artery bypass
graft (CABG) surgery can be high, the majority of patients
tend to return to their preoperative baseline neurocognitive
status.5 Studies have also demonstrated that patients with
early POCDs are at greater risk for long-term neurocogni-
tive decline at 5 years.6-8
Themechanisms of POCDs continue to be debated and are
likely multifactorial. Predictors of the occurrence of POCDs
include underlying cerebrovascular disease, advanced age,
length of cardiopulmonary bypass (CPB) time, manipulation
of the ascending aorta, and cerebral hyperthermia.9,10
Other less consistently demonstrated predictors of POCDs
include hypertension, diabetes, dementia, peripheral vascular
disease, and lower educational level.10,11
Most studies look for predictors and methods of reducing
POCDs, but no study has thoroughly investigated the true
clinical impact of these deficits.1,6,9,12 When QOL was
measured in patients having POCDs, QOL and productive
working status were both significantly reduced compared
with those in patients without POCDs. Conversely, most
studies investigating the impact of change in QOL after
CABG surgery revealed overall improvements in QOL.13,14
Given that this study did not measure preoperative QOL
and thus did not calculate the change in QOL, attributing
reduced QOL to POCDs cannot be fully concluded.12diovascular Surgery c Volume 145, Number 6 1545
Abbreviations and Acronyms
CABG ¼ coronary artery bypass graft
CPB ¼ cardiopulmonary bypass
ICU ¼ intensive care unit
POCD ¼ postoperative neurocognitive deficit
QOL ¼ quality of life
SF-12
(or -36)
¼ Short Form Health Survey-12
(or -36)
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POCDs in a large cohort of patients undergoing on-pump
CABG surgery. A variety of variables assessing mortality,
morbidity, and QOL were assessed in all patients and their
relationship to POCDs was examined.PATIENTS AND METHODS
Patient Population
The study population consisted of 696 patients over the age of 60 years
who had been accepted for nonurgent CABG surgery at the University of
Ottawa Heart Institute between 1995 and 2004. This cohort of patients
had been previously enrolled in 3 separate randomized trials evaluating
the effects of intraoperative temperature and cell salvage on POCDs.15-17
Further details were reviewed by Boodhwani and associates9 in 2006.
The study protocols were approved by the Institutional Review Board of
the University of Ottawa Heart Institute and written informed consent
was obtained from all subjects.
Patients included in the trial were more than the age of 60 years, fluent in
either English or French, and undergoing nonemergency CABG surgery.
Patients were excluded if they had a preoperative neurologic deficit of
any etiology, Parkinson disease, physical disability preventing neuropsy-
chometric testing, Mini-Mental Status Exam score less than 24, on intrave-
nous nitroglycerin, documented coagulopathy (or international normalized
ratio>1.3), significant renal dysfunction (serum creatinine>2 times nor-
mal), and preoperative atrial fibrillation.
Intraoperative Protocol
The protocol for the various study-related interventions has been previ-
ously described.9,15,16,18 All procedures were performed through a median
sternotomy approach using CPB instituted via cannulation of the ascending
aorta and a 2-stage right atrial cannulation along with a membrane oxygen-
ator and a 43-mm arterial line filter (Cobe Cardiovascular, Arvada, Colo),
with a nonpulsatile flow at 2.5 to 2.8 L/min/m2, and without the use of
left ventricular vents. Mean arterial pressure was maintained between 50
and 80 mm Hg using phenylephrine or isoflurane. After the aortic cross-
clamp was applied, cardiac arrest was initiated and maintained with ante-
grade cold blood cardioplegia. Proximal anastomoses were performed
either using a side-biting clamp on the aorta or while on CPB. Tranexamic
acid was given to patients to reduce blood loss. Standardized protocols
were used for postoperative care.
Neuropsychometric Evaluation
Testing was conducted in accordance with the consensus statement on
neurobehavioral evaluation after cardiac surgery.19 A battery of 14 tests di-
vided into 4 domains assessing memory, attention, speed, and psychomotor
function were performed on patients preoperatively, at hospital discharge,
and at 3 months’ follow-up. Learning efficiency and memory consolidation1546 The Journal of Thoracic and Cardiovascular Surwere evaluated with a verbal list learning procedure (Buschke Selective Re-
minding administration and scoring or Rey Auditory and Verbal Learning
Test). Attention span was evaluated with the Wechsler Adult Intelligence
Scale-Revised Digit Span. Speed and motor domains were assessed by Fin-
ger Tapping Test, and Letter and Category Fluencywas used to assess speed
and flexibility of verbal thought processes. Psychomotor function was mea-
sured by Trails A and B, Grooved Pegboard, and Symbol Digit Modalities
Test (oral administration). Neurocognitive testing was performed at all
time points under similar conditions and, whenever possible, by the same
evaluator. Alternate forms were used to reduce learning effects. To opti-
mize reliability of the neuropsychometric evaluation, we had the psycho-
metrists trained and periodically audited by the same neuropsychologist.
All patients were ambulating and fit for discharge at the time of postoper-
ative neuropsychometric testing.
QOL was measured either by the Short Form Health Survey-36
(SF-36)20 or the equivalent condensed Short Form Health Survey-12
(SF-12).21 The total battery of tests required approximately 60 minutes
to administer.Statistical Analysis
Neuropsychometric results were analyzed both as continuous and di-
chotomous outcomes. Individual psychometric test scores yielded contin-
uous measures repeated at 3 time points including preoperative, at
hospital discharge, and at 3 months’ follow-up.
For categorical analysis, the neuropsychometric tests were combined
into 4 cognitive domains using factor analysis with orthogonal rotation as
detailed byNewman and coworkers.6 This reduced the individual test scores
into 4 factors that were uncorrelated and accounted for 80% of the variance
present in the test battery corresponding to the following areas of cognitive
functioning: verbal memory, attention, motor function, and psychomotor
speed and dexterity. The scores were adjusted so that an increase in score
always indicated better performance, and a composite score was formed
by adding the 4 factors (composite cognitive index). A patient was deemed
to have had a POCD if 1 or more factor scores decreased by at least 1 stan-
dard deviation. A secondary analysis was also performed using reliable
change index methodology to account for practice effects. A cohort of 75
nonsurgical control subjects with coronary artery disease was tested at the
same intervals, and this information was used to adjust for practice learning
effects in the study patients as described by Rasmussen and colleagues.22
QOL data, obtained from the SF-12 or SF-36 questionnaires, were ana-
lyzed separately for the physical and mental domains. QOL scores were
normalized using the preoperative (baseline) scores, and percent change
at 3 months was calculated for all patients. Logistic and linear regression
models were constructed to examine predictors of POCDs and of QOL,
respectively.
Data are presented as mean  standard deviation or median (interquar-
tile range). Odds ratios are presented with their 95% confidence intervals.
Continuous variables were compared by using unpaired t tests if normally
distributed or the Wilcoxon rank-sum test for nonnormally distributed con-
tinuous variables. Categorical data were compared using c2 or Fisher exact
tests. A liberal threshold of P<.20 was used to select variables for the con-
struction of the multivariable logistic regression model. This model was
constructed by first choosing the best single variable model as determined
by the likelihood ratio test. The next covariate to be added was identified by
considering all possible 2-variable models and selecting the one with the
greatest likelihood. New variables were then added to the model until the
addition of covariates no longer significantly improved the model. All
the significant univariate predictors that did not enter the final model
were individually added to the final model to assess confounding. The lin-
earity assumption for continuous predictors was evaluated by dividing the
variable into equal width bins and examining the adjusted odds ratio across
the bins. Finally, the model was boot-strapped 1000 times to assess whether
the model was overfit. All analyses were conducted in SAS version 9.1
(SAS Institute, Inc, Cary, NC).gery c June 2013
TABLE 1. Preoperative and intraoperative variables in patients with
or without POCDs demonstrating no significant differences (expressed
either as mean or percentage ± standard error of the mean)
Variable
No POCD
(n ¼ 531)
POCD
(n ¼ 121)
P
value
Age 64  9 66  9 .19
Hypertension 268 (67%) 67 (74%) .14
Diabetes 162 (31%) 42 (35%) .44
LV dysfunction 183 (34%) 40 (33%) .76
Severe angina (class III/IV) 356 (67%) 77 (64%) .47
Male gender 470 (89%) 106 (88%) .79
BMI 29.1  4.5 29.2  4.9 .76
Serum creatinine 92  18 91  20 .73
Hematocrit 41  4 42  4 .10
Carotid disease 19 (5.7%) 2 (2.5%) .39
Peripheral vascular disease 41 (12%) 13 (16%) .36
CPB time 86  28 82  25 .12
No. of bypass grafts 3.1  0.7 3.1  0.7 .72
POCD, Postoperative neurocognitive deficit; LV, left ventricular; BMI, body mass
index; CPB, cardiopulmonary bypass.
TABLE 2. Postoperative variables in patients with or without POCDs
(expressed either as mean or percentage ± standard error of the mean)
Variable
No POCD
(n ¼ 531)
POCD
(n ¼ 121)
P
value
Three-month mortality 2 (0.4%) 0 .66
Postop MI 9 (1.7%) 0 .22
Reopening for bleeding 20 (3.7%) 6 (4.9%) .68
Prolonged ICU stay (>48 h) 66 (12%) 26 (21%) .01
ICU LOS 1.3  1.3 1.8  2.9 .03
Hospital LOS 6.4  3.0 6.8  5.3 .11
Surgical site infection 12 (2.3%) 3 (2.5%) .74
Length of ventilation (h) 12  18 16  41 .19
POCDs, Postoperative neurocognitive deficits; MI, myocardial infarction; ICU,
intensive care unit; LOS, length of stay.
TABLE 3. Multivariate regression analysis model demonstrating
predictors of POCDs at discharge and 3 months after CABG surgery
Variable Odds ratio 95% CI P value
At discharge
Diabetes 1.95 1.39-2.73 <.0001
Preop creatinine 1.02 1.01-1.03 <.003
CPB time 1.01 1.00-1.02 .008
At 3 months
Prolonged ICU stay 1.92 1.16-3.19 .01
POCDs, Postoperative neurocognitive deficits; CABG, coronary artery bypass graft;
CI, confidence interval; CPB, cardiopulmonary bypass; ICU, intensive care unit.
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DRESULTS
POCDs were observed in 38% of patients (n ¼ 265/696)
at discharge from the hospital and 19% (n ¼ 132/696) at 3
months’ follow-up. In patients aged 75 years or older, the
incidence of POCDs at discharge was 43% whereas the in-
cidence in patients under 75 years of age was 37%
(P ¼ .29). Three months after the operation, patients over
the age of 75 had a 25% incidence of POCDs compared
with 18% in those less than 75 years of age (P ¼ .15).
Of patients in whom POCDs were diagnosed at 3 months,
97% (n¼ 117) had deficits in just 1 domain and 3% (n¼ 4)
of patients noticed deficits in 2 domains or more. From the
132 (19% of total) patients who had POCDs at 3 months,
only 54 (41%) had deficits in the same neuropsychiatric do-
mains as at the time of discharge. Completeness of follow-
up was achieved in 100% before the operation, 99% after
discharge from the hospital, and 94% at 3 months. There
were no significant differences noted in preoperative and in-
traoperative variables in patients with or without POCDs
(Table 1).
The overall in-hospital mortality rate was 11 (1.6%) pa-
tients and the mortality rate of survivors at 3 months was 2
(0.3%). Postoperative outcomes comparing patients with
POCDs and those without are illustrated in Table 2. Patients
with POCDs had longer intensive care unit (ICU) stays
(P ¼ .03), and twice the number of patients with POCDs
had a prolonged ICU stay (>48 hours; P¼ .01). The overall
hospital length of stay was slightly but not significantly
greater in patients with POCDs (P ¼ .11). The incidence
of other postoperative outcomes including myocardial in-
farction, reopening for bleeding, surgical site infection,
and length of ventilation were similar between patients
with or without POCDs (Table 2).The Journal of Thoracic and CarNeurocognitive Outcomes
POCDs were defined as a reduction by at least 1 standard
deviation in more than 1 domain of interest. Predictors of
POCDs at discharge and at 3 months postoperatively were
determined by multivariate regression analysis (Table 3).
Predictors of POCDs at discharge from the hospital were
diabetes (P<.0001), increased preoperative creatinine level
(P ¼ .003), and longer CPB time (P ¼ .008). Three months
after the operation, the only independent predictor for POCDs
was prolonged ICU stay (>48 hours; P ¼ .01). Inasmuch as
this study compiled data from 3 randomized controlled trials,
the treatment conditions in each study were added into the
multivariable model demonstrating that these interventional
conditions were not significant predictors of POCDs.QOL Assessment
Baseline QOL was assessed preoperatively and was
compared with QOL 3months after the operation by admin-
istrating the SF-36 or the SF-12 test. At 3 months, patients
had significant improvements in both physical (34% 2%
increase from baseline) and mental (10%  1% increase
from baseline) components of QOL independent of the
occurrence of POCDs (P> .5). Using a multivariable re-
gression model, independent predictors of improved QOL
were determined and depicted in Table 4. The strongest pre-
dictors of improved QOL included younger age (P<.001),
severe preoperative anginal class (P< .001), absence of
postoperative sternal wound infection (P¼ .03), and normaldiovascular Surgery c Volume 145, Number 6 1547
TABLE 4. Predictors of improved QOL in patients undergoing
surgery
Variable Odds ratio 95% CI P value
Younger age 4.00 2.43-7.14 <.001
Severe CCS angina class 3.29 1.9-4.67 <.001
Normal LV ejection fraction 1.31 1.01-2.6 .04
Absence of sternal wound infection 9.65 1.2-18.1 .03
Absence of neurocognitive deficit 0.86 0.05-14.9 .92
CI, Confidence interval; CCS, canadian cardiovascular society; LV, left ventricular.
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sence of POCDs was not a predictor of improved QOL
(P ¼ .92) at 3 months after CABG.
DISCUSSION
In this large, single-center cohort of on-pump CABG pa-
tients undergoing comprehensive neuropsychometric evalu-
ation, we sought to determine the clinical impact of POCDs.
We found that the incidence of POCDs in this study was
38% at discharge followed by an expected decline to
19% at 3 months after CABG. Furthermore, elderly pa-
tients, those older than 75 years of age, had similar inci-
dences of POCDs when compared with younger patients.
Predictors of POCDs at discharge included longer CPB
time, higher preoperative creatinine level, and diabetes; at
3 months, only prolonged ICU stay was associated with
POCDs. The occurrence of POCDs was not associated
with increased morbidity or increased hospital stay. Impor-
tantly, we found that although patients had significant im-
provements in physical and mental domains of QOL after
surgery, these improvements were independent of the oc-
currence of POCDs. In summary, this study demonstrates
that in patients undergoing CABG surgery, POCDs do not
significantly affect clinical outcomes including morbidity,
mortality, and QOL.
There was no observed clinically significant difference in
mortality or morbidity in patients with or without POCDs in
this study. Patients who had POCDs did have statistically
significantly longer ICU stay (P ¼ .03) by an average of
0.5 days, along with a trend toward longer hospital stay
(P ¼ .11); however, other postoperative complications in-
cluding length of ventilation, reexploration for bleeding,
myocardial infarction, and mortality were similar in both
groups. Independent predictors of developing POCDs at
discharge included diabetes, increased preoperative creati-
nine level, and prolonged CPB time, all of which are known
risk factors for the development of POCDs. Three months
after CABG, only prolonged ICU stay was associated
with a higher chance of developing POCDs, whereas the
determined predictors of developing POCD at discharge
(diabetes, creatinine, CPB) were not present at 3 months.
The reasons for the differences may be because of the lower
number of patients with POCDs at 3 months or that pro-
longed ICU stay is more likely to occur in and therefore1548 The Journal of Thoracic and Cardiovascular Surmay be a surrogate marker for patients with a higher burden
of comorbidities and more challenging operations.
Postoperative QOLwas assessed with either SF-36 or SF-
12 in all patients undergoing surgery and was compared
with their baseline levels. Both components of QOL (men-
tal and physical) were improved from baseline independent
of the presence of POCDs (P>.5). Although most patients
undergoing CABG surgery do note an improvement in
QOL when compared with baseline,13,14 Newman and
colleagues12 demonstrated a direct correlation between in-
creased neurocognitive decline at 5 years with decreased
QOL and lower general health status. Inasmuch as patients
experiencing POCDs and late cognitive decline are likely to
have a higher burden of comorbidities and are also likely to
have poorer baseline QOL, it is difficult to conclude a caus-
ative relationship between POCDs and QOL from this study
because baseline QOL scores were not measured. In our
study, we compared the change in QOL after surgery in
both patients with and without POCDs, and no significant
difference was appreciated. Furthermore, we adjusted for
other variables that are associated with POCDs that may
have been different between groups. Even after multivariate
analyses for predictors of increased QOL after CABG, the
absence or the presence of POCDs was not linked (odds
ratio ¼ 0.86; P value ¼ .92). The strongest predictors of
increased QOL were found to be younger age, higher
Canadian Cardiovascular Society angina class, absence of
sternal wound infection, and normal ejection fraction.
This finding abrogates the notion that POCDs after CABG
lead to a poorer QOL and overall general health status.
This study was aimed at elucidating the clinical impact of
POCDs in on-pump CABG patients, and we found that
there was no appreciable clinical impact or any effect on
QOL. These findings, combined with previously published
reports, can help to shed light on the nature, mechanism,
and relevance of POCDs. Early studies examining this issue
identified POCDs as a frequent occurrence associated with
late cognitive decline. Their occurrence was attributed to
the use and management of CPB. However, several groups
have since demonstrated that there are no differences in
early and late POCDs between patients undergoing on-
pump versus off-pump surgery.23,24 Various studies have
also examined specific CPB management strategies
including temperature and use of cell salvage devices and
have yielded inconclusive and mixed results.16-18 Recent
studies have also demonstrated that when CABG patients
are compared with appropriately controlled nonsurgical
patients with coronary artery disease, the incidence of
POCDs is similar at 1 year, suggesting that the preoperative
status and preexisting cerebrovascular disease play a more
direct role in developing POCDs than the operation itself.25
Furthermore, patients with known coronary artery disease
aremore prone to cognitive decline after any formof interven-
tion (percutaneous coronary intervention or CABG) than aregery c June 2013
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tematic review determined that the incidence of early and late
POCDs after noncardiac surgery was similar and that various
treatment strategies to reduce the number of POCDs had no
significant impact on patient outcomes.2 Of the 132 patients
who had POCDs at 3 months, only 41% had deficits in the
same neuropsychiatric domains seen at discharge. This im-
plies that the majority of patients had deficits develop in
new domains between the time of hospital discharge and at
3 months of follow-up, further corroborating the concept
that POCDs are not likely to be related to the surgery.
Combined with our data, these studies suggest that POCDs
may be a marker of underlying cerebrovascular disease that
is unmasked owing to the stress of a cardiac surgical proce-
dure. These findings also have implications for clinical trials
designed to reduce the occurrence of POCDs.
The limitations to this study include the fact that this is
a homogeneous, single-center cohort of relatively low-risk
patients undergoing coronary surgery and that the results
may not be generalizable to other patients undergoing car-
diac surgery. Inasmuch as this study combined patients
from 3 prospective randomized controlled trials from our
institution, confounding variables created by different trial
interventions and allocations could potentially affect the con-
clusions made.15-17 However, all 3 trials, when examined
individually, did not show any differences in morbidity,
mortality, or QOL. Also, these interventional conditions
were applied to the multivariate analysis concluding that
treatment allocation was not a significant predictor of
POCDs. Another limitation relates to the definition of
POCDs. Although there is no universally accepted definition,
the criteria used in this study yielded an incidence of
POCDs that is similar to that which has been reported
previously. Differences in POCD definition could have
theoretically led to some alterations in study findings.
CONCLUSIONS
POCDs occur frequently after cardiac surgery and are
likely affected by preoperative, intraoperative, and postop-
erative factors. POCDs are not associated with increased
mortality, morbidity, or longer hospital stay. Patients under-
going surgical coronary revascularization uniformly have
improvements in QOL that are not affected by POCD occur-
rence. Although the pathogenesis of POCDs remains uncer-
tain, it is likely that they are a marker of underlying
cerebrovascular disease unmasked during amajor operation.
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